https://ir.castlebiosciences.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/castlebiosciences/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.castlebiosciences.com/news-events/press-releases/detail/469/castle-biosciences-to-present-at-the-2026-jefferies-global-healthcare-conference Wed, 13 May 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/469/castle-biosciences-to-present-at-the-2026-jefferies-global-healthcare-conference https://ir.castlebiosciences.com/news-events/press-releases/detail/468/castle-biosciences-advancead-tx-test-receives-2026-medtech-breakthrough-award-for-genomics-innovation Tue, 12 May 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/468/castle-biosciences-advancead-tx-test-receives-2026-medtech-breakthrough-award-for-genomics-innovation https://ir.castlebiosciences.com/news-events/press-releases/detail/467/castle-biosciences-reports-first-quarter-2026-results Wed, 06 May 26 16:05:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/467/castle-biosciences-reports-first-quarter-2026-results https://ir.castlebiosciences.com/news-events/press-releases/detail/466/castle-biosciences-supports-nationwide-patient-advocacy-and-screening-initiatives-to-celebrate-skin-cancer-awareness-month Tue, 05 May 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/466/castle-biosciences-supports-nationwide-patient-advocacy-and-screening-initiatives-to-celebrate-skin-cancer-awareness-month https://ir.castlebiosciences.com/news-events/press-releases/detail/465/new-data-at-ddw-2026-show-tissuecypher-testing-improves-risk-stratification-and-drives-risk-aligned-management-in-barretts-esophagus Mon, 04 May 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/465/new-data-at-ddw-2026-show-tissuecypher-testing-improves-risk-stratification-and-drives-risk-aligned-management-in-barretts-esophagus https://ir.castlebiosciences.com/news-events/press-releases/detail/464/castle-biosciences-to-present-new-data-demonstrating-decisiondx-melanomas-ability-to-identify-patients-with-greater-risk-of-recurrence-and-poor-outcomes-within-early-stage-melanoma-at-eado-and-acms Tue, 21 Apr 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/464/castle-biosciences-to-present-new-data-demonstrating-decisiondx-melanomas-ability-to-identify-patients-with-greater-risk-of-recurrence-and-poor-outcomes-within-early-stage-melanoma-at-eado-and-acms https://ir.castlebiosciences.com/news-events/press-releases/detail/463/castle-biosciences-to-release-first-quarter-2026-financial-results-and-host-webcast-on-wednesday-may-6-2026 Wed, 15 Apr 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/463/castle-biosciences-to-release-first-quarter-2026-financial-results-and-host-webcast-on-wednesday-may-6-2026 https://ir.castlebiosciences.com/news-events/press-releases/detail/462/castle-biosciences-earns-2026-usa-today-top-workplaces-award-for-fifth-consecutive-year Fri, 10 Apr 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/462/castle-biosciences-earns-2026-usa-today-top-workplaces-award-for-fifth-consecutive-year https://ir.castlebiosciences.com/news-events/press-releases/detail/461/castle-biosciences-decisiondx-melanoma-test-significantly-improves-risk-prediction-within-ajcc-stages-to-support-personalized-risk-aligned-management-of-cutaneous-melanoma-data-to-be-presented-at-aad-2026 Fri, 27 Mar 26 09:05:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/461/castle-biosciences-decisiondx-melanoma-test-significantly-improves-risk-prediction-within-ajcc-stages-to-support-personalized-risk-aligned-management-of-cutaneous-melanoma-data-to-be-presented-at-aad-2026 https://ir.castlebiosciences.com/news-events/press-releases/detail/85/prospective-multi-center-study-published-in-future-oncology-demonstrates-decisiondx-melanomas-i31-slnb-result-outperforms-staging-criteria-in-identifying-patients-with-cutaneous-melanoma-below-the-5-nccn-threshold-for-forgoing-slnb Fri, 13 Mar 26 11:02:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/85/prospective-multi-center-study-published-in-future-oncology-demonstrates-decisiondx-melanomas-i31-slnb-result-outperforms-staging-criteria-in-identifying-patients-with-cutaneous-melanoma-below-the-5-nccn-threshold-for-forgoing-slnb